Delivery Order SPE2DX22D0010-SPE2D826FBM98
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Methylphenidate 2.5 mg chewable tablets (100 count) with a ceiling value of $7,107.77. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor. The order is set to reach completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, valued at $4,817.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Methylphenidate ER tablets in 36-milligram dosage. This is a firm fixed-price delivery order with a ceiling value of $3,312.60 and an ultimate completion date of December 8, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) valued at $4,498.98. This competitive award (no set-aside used) is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate HCL chewable tablets 5mg under a firm fixed-price arrangement. The contract, valued at $6,183.26, was competitively awarded without set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,513.64 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units). This competitive award with firm fixed pricing represents a non-set-aside contract and is scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $2,071.52. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 5, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units. The contract is valued at $2,017.97 and will be completed by June 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order valued at $5,384.48 on July 31, 2025, for the supply of Methylphenidate HCL Chewable Tablets 5mg to the Medical Supply Chain, a Defense-affiliated federal agency. This is a competitively awarded, non-set-aside contract utilizing firm fixed pricing, with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBM98Delivery Order
The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Methylphenidate HCL chewable tablets at 10mg strength. This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,128.45 and is scheduled for completion by December 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects open competition and demonstrates the contractor's continued capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's portfolio of federal contracts demonstrates extensive experience distributing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 12/3/25 |